Global Duchenne Muscular Dystrophy Market

Global Duchenne Muscular Dystrophy Market Research Report 2021

Global Duchenne Muscular Dystrophy Market

Global Duchenne Muscular Dystrophy Market Research Report 2021


Duchenne Muscular Dystrophy Market by End User (Office Building Construction, Retail Construction, Hospitality Construction, Institutional Construction, Other End Users), by North America (United States, Canada, Mexico), by South America (Brazil, Argentina, Rest of South America), by Europe (United Kingdom, Germany, France, Italy, Spain, Russia, Benelux, Nordics, Rest of Europe), by Middle East & Africa (Turkey, Israel, GCC, North Africa, South Africa, Rest of Middle East & Africa), by Asia Pacific (China, India, Japan, South Korea, ASEAN, Oceania, Rest of Asia Pacific) Forecast - is a comprehensive report that provides insights into the market dynamics, including the key drivers, challenges, and opportunities shaping the industry landscape. It also delves into the competitive landscape, highlighting the major players and their strategies.


Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!

Research Predicts that Duchenne Muscular Dystrophy Market was valued USD xxxx unit in 2020 and is expected to reach USD xxxx Unit by the year 2025, growing at a CAGR of xx% globally.

Global Duchenne Muscular Dystrophy Market Overview:

Global Duchenne Muscular Dystrophy Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2020-2025.This research study of Duchenne Muscular Dystrophy involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.

Impact of COVID-19 on Duchenne Muscular Dystrophy Market

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the Duchenne Muscular Dystrophy market in 2020.

Global Duchenne Muscular Dystrophy Market Segmentation

By Type, Duchenne Muscular Dystrophy market has been segmented into:

Deflazacort

Prednisone

Others

By Application, Duchenne Muscular Dystrophy market has been segmented into:

Male

Female

Regional Analysis:

North America (U.S., Canada, Mexico)

Europe (Germany, U.K., France, Italy, Russia, Spain etc.)

Asia-Pacific (China, India, Japan, Southeast Asia etc.)

South America (Brazil, Argentina etc.)

Middle East & Africa (Saudi Arabia, South Africa etc.)

Top Key Players Covered in Duchenne Muscular Dystrophy market are:

PTC Therapeutics

Sarepta Therapeutics

Bristol-Myers Squibb

ITALFARMACO

BioMarin

Daiichi Sankyo

Solid Biosciences

Summit Therapeutics

FibroGen

NS Pharma

Pfizer

ReveraGen BioPharma

Wave Life

Genethon

Santhera Pharmaceuticals

1. Market Overview of Duchenne Muscular Dystrophy

1.1 Duchenne Muscular Dystrophy Market Overview

1.1.1 Duchenne Muscular Dystrophy Product Scope

1.1.2 Market Status and Outlook

1.2 Duchenne Muscular Dystrophy Market Size by Regions: 2015 VS 2021 VS 2026

1.3 Duchenne Muscular Dystrophy Historic Market Size by Regions (2015-2020)

1.4 Duchenne Muscular Dystrophy Forecasted Market Size by Regions (2021-2026)

1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)

1.5.1 North America

1.5.2 East Asia

1.5.3 Europe

1.5.4 South Asia

1.5.5 Southeast Asia

1.5.6 Middle East

1.5.7 Africa

1.5.8 Oceania

1.5.9 South America

1.5.10 Rest of the World

1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

1.6.2 Covid-19 Impact: Commodity Prices Indices

1.6.3 Covid-19 Impact: Global Major Government Policy

2. Covid-19 Impact Duchenne Muscular Dystrophy Sales Market by Type (2015-2026)

2.1 Global Duchenne Muscular Dystrophy Historic Market Size by Type (2015-2020)

2.2 Global Duchenne Muscular Dystrophy Forecasted Market Size by Type (2021-2026)

2.3 Deflazacort

2.4 Prednisone

2.5 Others

3. Covid-19 Impact Duchenne Muscular Dystrophy Sales Market by Application (2015-2026)

3.1 Global Duchenne Muscular Dystrophy Historic Market Size by Application (2015-2020)

3.2 Global Duchenne Muscular Dystrophy Forecasted Market Size by Application (2021-2026)

3.3 Male

3.4 Female

4. Covid-19 Impact Market Competition by Manufacturers

4.1 Global Duchenne Muscular Dystrophy Production Capacity Market Share by Manufacturers (2015-2020)

4.2 Global Duchenne Muscular Dystrophy Revenue Market Share by Manufacturers (2015-2020)

4.3 Global Duchenne Muscular Dystrophy Average Price by Manufacturers (2015-2020)

5. Company Profiles and Key Figures in Duchenne Muscular Dystrophy Business

5.1 PTC Therapeutics

5.1.1 PTC Therapeutics Company Profile

5.1.2 PTC Therapeutics Duchenne Muscular Dystrophy Product Specification

5.1.3 PTC Therapeutics Duchenne Muscular Dystrophy Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.2 Sarepta Therapeutics

5.2.1 Sarepta Therapeutics Company Profile

5.2.2 Sarepta Therapeutics Duchenne Muscular Dystrophy Product Specification

5.2.3 Sarepta Therapeutics Duchenne Muscular Dystrophy Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.3 Bristol-Myers Squibb

5.3.1 Bristol-Myers Squibb Company Profile

5.3.2 Bristol-Myers Squibb Duchenne Muscular Dystrophy Product Specification

5.3.3 Bristol-Myers Squibb Duchenne Muscular Dystrophy Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.4 ITALFARMACO

5.4.1 ITALFARMACO Company Profile

5.4.2 ITALFARMACO Duchenne Muscular Dystrophy Product Specification

5.4.3 ITALFARMACO Duchenne Muscular Dystrophy Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.5 BioMarin

5.5.1 BioMarin Company Profile

5.5.2 BioMarin Duchenne Muscular Dystrophy Product Specification

5.5.3 BioMarin Duchenne Muscular Dystrophy Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.6 Daiichi Sankyo

5.6.1 Daiichi Sankyo Company Profile

5.6.2 Daiichi Sankyo Duchenne Muscular Dystrophy Product Specification

5.6.3 Daiichi Sankyo Duchenne Muscular Dystrophy Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.7 Solid Biosciences

5.7.1 Solid Biosciences Company Profile

5.7.2 Solid Biosciences Duchenne Muscular Dystrophy Product Specification

5.7.3 Solid Biosciences Duchenne Muscular Dystrophy Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.8 Summit Therapeutics

5.8.1 Summit Therapeutics Company Profile

5.8.2 Summit Therapeutics Duchenne Muscular Dystrophy Product Specification

5.8.3 Summit Therapeutics Duchenne Muscular Dystrophy Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.9 FibroGen

5.9.1 FibroGen Company Profile

5.9.2 FibroGen Duchenne Muscular Dystrophy Product Specification

5.9.3 FibroGen Duchenne Muscular Dystrophy Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.10 NS Pharma

5.10.1 NS Pharma Company Profile

5.10.2 NS Pharma Duchenne Muscular Dystrophy Product Specification

5.10.3 NS Pharma Duchenne Muscular Dystrophy Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.11 Pfizer

5.11.1 Pfizer Company Profile

5.11.2 Pfizer Duchenne Muscular Dystrophy Product Specification

5.11.3 Pfizer Duchenne Muscular Dystrophy Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.12 ReveraGen BioPharma

5.12.1 ReveraGen BioPharma Company Profile

5.12.2 ReveraGen BioPharma Duchenne Muscular Dystrophy Product Specification

5.12.3 ReveraGen BioPharma Duchenne Muscular Dystrophy Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.13 Wave Life

5.13.1 Wave Life Company Profile

5.13.2 Wave Life Duchenne Muscular Dystrophy Product Specification

5.13.3 Wave Life Duchenne Muscular Dystrophy Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.14 Genethon

5.14.1 Genethon Company Profile

5.14.2 Genethon Duchenne Muscular Dystrophy Product Specification

5.14.3 Genethon Duchenne Muscular Dystrophy Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.15 Santhera Pharmaceuticals

5.15.1 Santhera Pharmaceuticals Company Profile

5.15.2 Santhera Pharmaceuticals Duchenne Muscular Dystrophy Product Specification

5.15.3 Santhera Pharmaceuticals Duchenne Muscular Dystrophy Production Capacity, Revenue, Price and Gross Margin (2015-2020)

6. North America

6.1 North America Duchenne Muscular Dystrophy Market Size (2015-2026)

6.2 North America Duchenne Muscular Dystrophy Key Players in North America (2015-2020)

6.3 North America Duchenne Muscular Dystrophy Market Size by Type (2015-2020)

6.4 North America Duchenne Muscular Dystrophy Market Size by Application (2015-2020)

7. East Asia

7.1 East Asia Duchenne Muscular Dystrophy Market Size (2015-2026)

7.2 East Asia Duchenne Muscular Dystrophy Key Players in North America (2015-2020)

7.3 East Asia Duchenne Muscular Dystrophy Market Size by Type (2015-2020)

7.4 East Asia Duchenne Muscular Dystrophy Market Size by Application (2015-2020)

8. Europe

8.1 Europe Duchenne Muscular Dystrophy Market Size (2015-2026)

8.2 Europe Duchenne Muscular Dystrophy Key Players in North America (2015-2020)

8.3 Europe Duchenne Muscular Dystrophy Market Size by Type (2015-2020)

8.4 Europe Duchenne Muscular Dystrophy Market Size by Application (2015-2020)

9. South Asia

9.1 South Asia Duchenne Muscular Dystrophy Market Size (2015-2026)

9.2 South Asia Duchenne Muscular Dystrophy Key Players in North America (2015-2020)

9.3 South Asia Duchenne Muscular Dystrophy Market Size by Type (2015-2020)

9.4 South Asia Duchenne Muscular Dystrophy Market Size by Application (2015-2020)

10. Southeast Asia

10.1 Southeast Asia Duchenne Muscular Dystrophy Market Size (2015-2026)

10.2 Southeast Asia Duchenne Muscular Dystrophy Key Players in North America (2015-2020)

10.3 Southeast Asia Duchenne Muscular Dystrophy Market Size by Type (2015-2020)

10.4 Southeast Asia Duchenne Muscular Dystrophy Market Size by Application (2015-2020)

11. Middle East

11.1 Middle East Duchenne Muscular Dystrophy Market Size (2015-2026)

11.2 Middle East Duchenne Muscular Dystrophy Key Players in North America (2015-2020)

11.3 Middle East Duchenne Muscular Dystrophy Market Size by Type (2015-2020)

11.4 Middle East Duchenne Muscular Dystrophy Market Size by Application (2015-2020)

12. Africa

12.1 Africa Duchenne Muscular Dystrophy Market Size (2015-2026)

12.2 Africa Duchenne Muscular Dystrophy Key Players in North America (2015-2020)

12.3 Africa Duchenne Muscular Dystrophy Market Size by Type (2015-2020)

12.4 Africa Duchenne Muscular Dystrophy Market Size by Application (2015-2020)

13. Oceania

13.1 Oceania Duchenne Muscular Dystrophy Market Size (2015-2026)

13.2 Oceania Duchenne Muscular Dystrophy Key Players in North America (2015-2020)

13.3 Oceania Duchenne Muscular Dystrophy Market Size by Type (2015-2020)

13.4 Oceania Duchenne Muscular Dystrophy Market Size by Application (2015-2020)

14. South America

14.1 South America Duchenne Muscular Dystrophy Market Size (2015-2026)

14.2 South America Duchenne Muscular Dystrophy Key Players in North America (2015-2020)

14.3 South America Duchenne Muscular Dystrophy Market Size by Type (2015-2020)

14.4 South America Duchenne Muscular Dystrophy Market Size by Application (2015-2020)

15. Rest of the World

15.1 Rest of the World Duchenne Muscular Dystrophy Market Size (2015-2026)

15.2 Rest of the World Duchenne Muscular Dystrophy Key Players in North America (2015-2020)

15.3 Rest of the World Duchenne Muscular Dystrophy Market Size by Type (2015-2020)

15.4 Rest of the World Duchenne Muscular Dystrophy Market Size by Application (2015-2020)

16 Duchenne Muscular Dystrophy Market Dynamics

16.1 Covid-19 Impact Market Top Trends

16.2 Covid-19 Impact Market Drivers

16.3 Covid-19 Impact Market Challenges

16.4 Porter’s Five Forces Analysis

18 Regulatory Information

17 Analyst's Viewpoints/Conclusions

18 Appendix

18.1 Research Methodology

18.1.1 Methodology/Research Approach

18.1.2 Data Source

18.2 Disclaimer

Research Methodology:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Duchenne Muscular Dystrophy Market Size Estimation

To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.

Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.

Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.

We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.

Data Source

Secondary Sources

This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.

These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Market Intellix Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Market Intellix Data Repository

Primary Sources

As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.

On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.

These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2025-2031)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2025-2031)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2025-2031)
Frequently asked questions(FAQ's):
Who are the dominant players having a strong presence in the Duchenne Muscular Dystrophy Market?
Some of the finest and top-notch companies pioneering the Duchenne Muscular Dystrophy Market are PTC Therapeutics, Sarepta Therapeutics, Bristol-Myers Squibb, ITALFARMACO, BioMarin, Daiichi Sankyo, Solid Biosciences, Summit Therapeutics, FibroGen, NS Pharma, Pfizer, ReveraGen BioPharma, Wave Life, Genethon, Santhera Pharmaceuticals.
How is the competition changing gears in the Duchenne Muscular Dystrophy Industry?
Emerging markets will create new demands and put pressure on the industry to act quickly. Simultaneously, market players such as PTC Therapeutics, Sarepta Therapeutics, Bristol-Myers Squibb, ITALFARMACO, BioMarin, Daiichi Sankyo, Solid Biosciences, Summit Therapeutics, FibroGen, NS Pharma, Pfizer, ReveraGen BioPharma, Wave Life, Genethon, Santhera Pharmaceuticals will face challenges from the industry's increasing pace of consolidation, particularly in North America and Europe.
What are the major applications of the Duchenne Muscular Dystrophy Market?
Depending upon the type of applications, the Duchenne Muscular Dystrophy Market has been segmented into and other applications.
What years are taken into account in the Duchenne Muscular Dystrophy Market study?
The Duchenne Muscular Dystrophy Market study evaluates the year spans as follows: Historical year: 2019 to 2024; Base year: 2024; Forecast period**: 2025 to 2030 [** unless otherwise stated]
In the current situation, what value does the Duchenne Muscular Dystrophy Market have?
The value of the Duchenne Muscular Dystrophy Market is estimated to be USD XXX million.
Who should consider the Duchenne Muscular Dystrophy Market study?
The Duchenne Muscular Dystrophy Industry stakeholders, executives, and experts, as well as individuals who need to develop consumer-friendly strategies and use technology to stay ahead of the competition.